These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 29871201)
21. Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter. Yao Z; Yin P; Su D; Peng Z; Zhou L; Ma L; Guo W; Ma L; Xu G; Shi J; Jiao B Mol Biosyst; 2011 Sep; 7(9):2608-14. PubMed ID: 21713270 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China. Song Q; Wang D; Lou Y; Li C; Fang C; He X; Li J Diagn Pathol; 2011 Dec; 6():126. PubMed ID: 22188859 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma. Zhang M; Wu W; Gao M; Fei Z Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849 [TBL] [Abstract][Full Text] [Related]
24. Elevated expression of nuclear protein kinase CK2α as a poor prognosis indicator in lymph node cancerous metastases of human thyroid cancers. Guo M; Liu C; Qi FJ; Zhang XM; Ren LL; Liu YM; Meng ZC; Zhu ZT; Xiao JY Asian Pac J Cancer Prev; 2014; 15(17):7425-32. PubMed ID: 25227853 [TBL] [Abstract][Full Text] [Related]
25. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter. Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145 [TBL] [Abstract][Full Text] [Related]
26. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma. Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154 [TBL] [Abstract][Full Text] [Related]
27. Higher urinary bisphenol A concentration and excessive iodine intake are associated with nodular goiter and papillary thyroid carcinoma. Zhou Z; Zhang J; Jiang F; Xie Y; Zhang X; Jiang L Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28684549 [TBL] [Abstract][Full Text] [Related]
28. [An immunohistochemical study of CTHRC1,Vimentin,E-cadherin expression in papillary thyroid carcinoma]. Tang ZN; Wang YC; Liu XX; Liu QL Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 32(8):595-598. PubMed ID: 29798143 [No Abstract] [Full Text] [Related]
29. Lack of Variation in Inflammatory Hematological Parameters between Benign Nodular Goiter and Papillary Thyroid Cancer. Yaylaci S; Tosun O; Sahin O; Genc AB; Aydin E; Demiral G; Karahalil F; Olt S; Ergenc H; Varim C Asian Pac J Cancer Prev; 2016; 17(4):2321-3. PubMed ID: 27221938 [TBL] [Abstract][Full Text] [Related]
30. Potential Use of 1-25-dihydroxyvitamin D in the Diagnosis and Treatment of Papillary Thyroid Cancer. Zhang T; Zhang H; He L; Wang Z; Dong W; Sun W; Zhang P Med Sci Monit; 2018 Mar; 24():1614-1623. PubMed ID: 29553126 [TBL] [Abstract][Full Text] [Related]
31. Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions. Machairas N; Kostakis ID; Prodromidou A; Stamopoulos P; Feretis T; Garoufalia Z; Damaskos C; Tsourouflis G; Kouraklis G Endocr Res; 2017 Nov; 42(4):311-317. PubMed ID: 28506088 [TBL] [Abstract][Full Text] [Related]
32. MAGE-1, GAGE-1/-2 gene expression in FNAB of classic variant of papillary thyroid carcinoma and papillary hyperplasia in nodular goiter. Ruschenburg I; Kubitz A; Schlott T; Korabiowska M; Droese M Int J Mol Med; 1999 Oct; 4(4):445-8. PubMed ID: 10493989 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis. Kim HS; Lee JJ; Do SI; Kim K; Do IG; Kim DH; Chae SW; Sohn JH Int J Clin Exp Pathol; 2015; 8(5):5695-701. PubMed ID: 26191283 [TBL] [Abstract][Full Text] [Related]
34. Downregulation of serum DKK-1 predicts poor prognosis in patients with papillary thyroid cancer. Zhao YP; Wang W; Wang XH; Xu Y; Wang Y; Dong ZF; Zhang JJ Genet Mol Res; 2015 Dec; 14(4):18886-94. PubMed ID: 26782539 [TBL] [Abstract][Full Text] [Related]
35. Study of autophagy-related protein light chain 3 (LC3)-II expression levels in thyroid diseases. Zhang N; Li L; Wang J; Cao M; Liu G; Xie G; Yang Z; Li Y Biomed Pharmacother; 2015 Feb; 69():306-10. PubMed ID: 25661375 [TBL] [Abstract][Full Text] [Related]
37. The clinical implications of Crk-like adaptor protein expression in papillary thyroid microcarcinoma. Yang X; Lv W; Shi R; Cheng S; Zhang J; Xu Z Tumour Biol; 2014 Dec; 35(12):12435-40. PubMed ID: 25185652 [TBL] [Abstract][Full Text] [Related]
38. [Clinicopathologic characteristics of familial versus sporadic papillary thyroid carcinoma]. Liang J; Li Z; Li S; Huang B; Liu H; Li Y Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jun; 50(6):502-6. PubMed ID: 26695804 [TBL] [Abstract][Full Text] [Related]
39. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma. Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746 [TBL] [Abstract][Full Text] [Related]
40. Papillary Thyroid Cancer and Coexisting Autoimmune Thyroiditis. Veit F; Graf D; Momberger S; Helmich-Kapp B; Ruschenburg I; Peters A; Kussmann J; Saeger W; Schmidt KW; Toetsch M; Nestler K; Mann K Horm Metab Res; 2017 Nov; 49(11):869-872. PubMed ID: 29136676 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]